Cornell Stamoran serves as Vice President of Corporate Strategy and Government Affairs for Catalent Inc (NYSE: CTLT) and is a founder and chair of Catalent’s Applied Drug Delivery Institute. Cornell has worked in drug delivery for more than 30 years, spanning oral, injectable, respiratory, ophthalmic, and other routes of delivery, for drugs, biologics, cell and gene therapies, vaccines, and consumer health products. Cornell is a trustee of the Pharma/Biopharma Outsourcing Association, as well as current Treasurer and past Secretary; past board member and treasurer of the Controlled Release Society; and serves on the Editorial Advisory Board for several publications including Drug Development and Delivery magazine and several key industry conferences. Cornell has published more than three dozen articles on drug delivery, patient-focused drug design, and pharmaceutical outsourcing, and frequently speaks and posts on these topics. Cornell also serves on the cross-industry teams which negotiated GDUFA (II and III) and OMUFA (I and II) with the FDA.
Cornell Stamoran, Ph.D.
